Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

6 Dec 2018 07:00

RNS Number : 5857J
MJ Gleeson PLC
06 December 2018
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, convened for 11:30 am today in London, the Chairman, Dermot Gleeson, will state:

"Demand at Gleeson Homes is strong with net reservations up more than 40% over the last six months.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 12,490 plots with a gross development value of £1.5 billion, of which 7,253 plots are owned and 5,237 are conditionally purchased.

"Build activity has increased in recent months driven by strong demand. The division currently has 62 active sites, compared with 58 at this time last year.

"The Government's Help to Buy scheme remains popular with 71% of our customers taking advantage of it so far this financial year while other buyers continue to be attracted by our own bespoke purchaser assistance packages.

"Very strong customer demand in all regions, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means that the outlook for the division remains very positive.

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2018 of approximately 10% compared with the prior half year total of 593 units; and an increase in completions for the year to 30 June 2019 of more than 15% compared with the prior year total of 1,225 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. Since the start of the financial year the division has completed the sale of three sites with planning permission for a total of 483 plots and is progressing sale negotiations on a further 7 sites.

"The division's land pipeline currently consists of 58 sites which have the potential to deliver approximately 21,789 plots. The portfolio includes 9 sites which now have planning permission.

"Against this background, the Board remains confident that the Group's results for the full year to 30 June 2019 will be in line with expectations."

 

6 December 2018

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMDMMGZVKMGRZM
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.